Oragenics
OGEN
23 hedge funds and large institutions have $8.27M invested in Oragenics in 2021 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 8 increasing their positions, 4 reducing their positions, and 5 closing their positions.
116% more capital invested
Capital invested by funds: $3.83M → $8.27M (+$4.44M)
100% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 4
60% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 5
15% more funds holding
Funds holding: 20 → 23 (+3)
0% less ownership
Funds ownership: 0.01% → 0% (-0%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.12M |
| 2 |
BlackRock
New York
|
+$884K |
| 3 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$311K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$307K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$163K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
IAA
Independent Advisor Alliance
Charlotte,
North Carolina
|
-$1.89M |
| 2 |
VF
Virtu Financial
New York
|
-$143K |
| 3 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$54.5K |
| 4 |
Squarepoint
New York
|
-$13K |
| 5 |
TSS
Two Sigma Securities
New York
|
-$12.7K |
OGEN Hedge Fund Activity: Q1 2021 in Review
23 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Oragenics (OGEN) for Q1 2021, worth a combined $8.27M — up 116% from $3.83M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new OGEN positions and 5 closed out — a net gain of 3 holders — while 8 added to existing stakes and 4 trimmed.
The largest buyer was Vanguard Group, adding an estimated $3.12M. The largest seller was Independent Advisor Alliance, exiting entirely with an estimated $1.89M sold.
- 23 institutional investors held Oragenics (OGEN) as of Q1 2021, up from 20 in Q4 2020.
- Funds reported $8.27M of Oragenics stock for Q1 2021, up 116% quarter-over-quarter.
- 8 funds opened new Oragenics positions in Q1 2021 and 5 closed out, a net change of +3 holders.
- The largest Oragenics buyer in Q1 2021 was Vanguard Group, an estimated $3.12M added.
- The largest Oragenics seller in Q1 2021 was Independent Advisor Alliance, an estimated $1.89M sold.
Based on aggregated 13F filings for Q1 2021.